BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT00464646-completion@plaintrial.com
DTSTAMP:20261028T011316Z
DTSTART;VALUE=DATE:201405
SUMMARY:Therapy With Bevacizumab (BEV)\, Epirubicin\, and Cyclophosphamide 
 Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adj
 uvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breas
 t Cancer — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT00464646
URL:https://plaintrial.com/trial/NCT00464646
END:VEVENT
END:VCALENDAR